The Patent Finder

Pipeline Therapeutics, Inc.

Also on record
Records under this name other than patents Pipeline Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Pipeline Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,301,266Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,512,090Muscarinic acetylcholine M1 receptor antagonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,390,462Muscarinic acetylcholine M1 receptor antagonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,054,487Muscarinic Acetylcholine M1 Receptor Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,752,149Muscarinic acetylcholine M1 receptor antagonists
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,925,872Methods of treating cochlear synaptopathy
Formerly held
Lapsed on the fee record
Ended Feb 23, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 23, 2025USPTO record
US 10,865,188Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
Formerly held
Lapsed on the fee record
Ended Dec 15, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 15, 2024USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited